You are here

  • Home
  • Archive
  • Volume 82, Issue 5
  • Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme

Article metrics

Article menu
Rheumatoid arthritis
Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme

 

Online download statistics by month:

Online download statistics by month: February 2023 to August 2024

AbstractFullPdf
Feb 202312451202667
Mar 202310511024505
Apr 202313351335448
May 2023554549274
Jun 2023485465196
Jul 2023401373164
Aug 2023239227118
Sep 2023196179124
Oct 2023246226136
Nov 2023230211118
Dec 2023397364115
Jan 2024270225240
Feb 202425120396
Mar 2024173134152
Apr 2024432394127
May 2024316298114
Jun 2024314284127
Jul 202436535078
Aug 202421218955
Total871282323854